EUVIMEDEUVIMED entdecken
Leserbrief

Successful treatment of Bowen disease with 1% tirbanibulin ointment

Daniel Blaya Imbernón iD, Malena Finello iD, Carolina Labrandero Hoyos iD, Javier Lorca Spröhnle iD, Andrés Casanova Esquembre iD, Rodrigo Peñuelas Leal iD, Andrés Grau Echevarría iD, Pablo Hernández Bel iD

Clinical and Experimental Dermatology · 2023

DOI: 10.1093/ced/llad231 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Daniel Blaya Imbernón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Consorci Hospital General Universitari de Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Bowen's Disease, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report, to the best of our knowledge, the first case of Bowen disease treated with tirbanibulin. In addition to the successful treatment of the malignant lesions, the improvement in skin texture and photodamage is remarkable. With a good safety profile, tolerability and the dosing convenience of this new drug, we believe that its use in pathologies beyond Olsen grade 1 actinic keratoses is promising, but further studies are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bowen's DiseaseSkin NeoplasmsHumansOintmentsAcetamidesMorpholinesPyridines

Substanzen

OintmentsAcetamidestirbanibulinMorpholinesPyridines

Autor:innen und Institutionen

  • Department of Dermatology, Consorci Hospital General Universitari de Valencia, Valencia, Spain.

ORCID-Profile: Daniel Blaya Imbernón, Malena Finello, Carolina Labrandero Hoyos, Javier Lorca Spröhnle, Andrés Casanova Esquembre, Rodrigo Peñuelas Leal, Andrés Grau Echevarría, Pablo Hernández Bel

Zitieren

APA

Blaya Imbernón, D., Finello, M., Labrandero Hoyos, C., Lorca Spröhnle, J., Casanova Esquembre, A., Peñuelas Leal, R., Grau Echevarría, A., & Hernández Bel, P. (2023). Successful treatment of Bowen disease with 1% tirbanibulin ointment. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad231

Vancouver

Blaya Imbernón D, Finello M, Labrandero Hoyos C, Lorca Spröhnle J, Casanova Esquembre A, Peñuelas Leal R, et al. Successful treatment of Bowen disease with 1% tirbanibulin ointment. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad231

BibTeX
@article{BlayaImbernn2023,
  author = {Blaya Imbernón, Daniel and Finello, Malena and Labrandero Hoyos, Carolina and Lorca Spröhnle, Javier and Casanova Esquembre, Andrés and Peñuelas Leal, Rodrigo and Grau Echevarría, Andrés and Hernández Bel, Pablo},
  title = {Successful treatment of Bowen disease with 1% tirbanibulin ointment},
  journal = {Clinical and Experimental Dermatology},
  year = {2023},
  doi = {10.1093/ced/llad231}
}
Kostenlos starten →